![](/img/cover-not-exists.png)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Bigal, Marcelo E, Dodick, David W, Rapoport, Alan M, Silberstein, Stephen D, Ma, Yuju, Yang, Ronghua, Loupe, Pippa S, Burstein, Rami, Newman, Lawrence C, Lipton, Richard BLanguage:
english
Journal:
The Lancet Neurology
DOI:
10.1016/S1474-4422(15)00249-5
Date:
September, 2015
File:
PDF, 288 KB
english, 2015